Dow Up 0.09% Nasdaq Up 0.25%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.81 0.02(0.34%)
Prev Close:5.79
Open:N/A
Bid:5.80 x 1700
Ask:5.81 x 8700
1y Target Est:8.72
Beta:1.38
Next Earnings Date: 5-Nov-14ARIA Earnings announcement
Day's Range:5.72 - 5.89
52wk Range:2.15 - 9.83
Volume:N/A
Avg Vol (3m):7,453,950
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARIA

Comparison

Symbol% ChgMkt Cap
ARIAUp 0.34%N/A
NVSN/A
PFEN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback